Article Information
History
- August 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Annette Salomonsson1,
- Daniel Ehinger1,2,
- Mats Jönsson1,
- Johan Botling3,4,
- Patrick Micke4,
- Hans Brunnström5,6,
- Johan Staaf1,7 and
- Maria Planck1,8,9,*
- 1Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden
- 2Department of Genetics, Pathology, and Molecular Diagnostics, Skåne University Hospital, Helsingborg, Sweden
- 3Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- 4Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden
- 5Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden
- 6Department of Genetics, Pathology, and Molecular Diagnostics, Skåne University Hospital, Lund, Sweden
- 7Department of Laboratory Medicine, Division of Translational Cancer Research, Lund University, Lund, Sweden
- 8Department of Clinical Sciences Lund, Division of Respiratory Medicine, Allergology, and Palliative Medicine, Lund University, Lund, Sweden
- 9Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund, Sweden
- ↵*Corresponding author: maria.planck{at}med.lu.se
Posted August 29, 2024.
Gene expression-based identification of prognostic markers in lung adenocarcinoma
